Nanexa–Novo Nordisk PharmaShell Deal: From Validation to Development | Lucid Diligence Brief
This Lucid Diligence Brief examines the Nanexa–Novo Nordisk PharmaShell deal…
Mobile Health App Trends in H1 2026: Growth Outpaces Clinical Maturity
The mobile health app landscape is expanding, but space growth is moving faster…
Healthcare and Pharma Trends H1 2026: Innovation Shifts Toward Real-World Delivery
Healthcare and pharma trends in H1 2026 point to a common strategic change:…
Public Health Today—July 10, 2026
This week's public health update covers major epidemiological trends,…
Vaccines Today—July 10 2026
This week’s Vaccine Research update highlights regulatory momentum, clinical…
Respiratory Today—July 10, 2026
This week’s Respiratory Research update highlights regulatory progress,…
Cardiovascular Today—July 9, 2026
This week’s Cardiovascular update highlights evolving clinical evidence,…
Rare Diseases Today—July 9, 2026
This week’s Rare Diseases update highlights regulatory progress, clinical…
Cell and Gene Therapy Today—July 9, 2026
This week’s Gene and Cell Therapy update highlights regulatory progress,…
Women’s Health Today—July 8, 2026
This biweekly Women’s health video recap highlights regulatory approvals,…
Immunology Today—July 8, 2026
This week’s Immunology update highlights regulatory progress, late-stage…
Neuroscience Today—July 8, 2026
This week’s Neuroscience update highlights regulatory progress, advancing…